Suppr超能文献

载脂蛋白 E ε4 等位基因(阿尔茨海默病主要的迟发性发病风险基因)的年轻成年携带者,其扣带回后部的线粒体活性降低。

Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.

机构信息

Barrow Neurological Institute, St. Joseph's Hospital & Medical Center, Phoenix, AZ, USA.

出版信息

J Alzheimers Dis. 2010;22(1):307-13. doi: 10.3233/JAD-2010-100129.

Abstract

In vivo PET imaging studies of young-adult carriers of the apolipoprotein E ε4 allele (APOEε4), the major Alzheimer's disease (AD) susceptibility gene, have demonstrated declines in glucose metabolism in brain areas later vulnerable to AD, such as posterior cingulate cortex, decades before the possible onset of symptoms. We have previously shown in postmortem studies that such metabolic declines in AD are associated with brain regional mitochondrial dysfunction. To determine whether young adult at-risk individuals demonstrate similar mitochondrial functional decline, we histochemically assessed postmortem tissues from the posterior cingulate cortex of young-adult carriers and noncarriers of APOEε4. At-risk ε4 carriers had lower mitochondrial cytochrome oxidase activity than noncarriers in posterior cingulate cortex, particularly within the superficial cortical lamina, a pattern similar to that seen in AD patients. Except for one 34 year-old ε4 homozygote, the ε4 carriers did not have increased soluble amyloid-β, histologic amyloid-β, or tau pathology in this same region. This functional biomarker may prove useful in early detection and tracking of AD and indicates that mitochondrial mechanisms may contribute to the predisposition to AD before any evidence of amyloid or tau pathology.

摘要

在载脂蛋白 E ε4 等位基因(APOEε4)的年轻成年携带者(阿尔茨海默病(AD)的主要易感基因)的体内正电子发射断层扫描成像研究中,已经证明了大脑中葡萄糖代谢的下降,这些区域以后容易受到 AD 的影响,如后扣带皮层,在可能出现症状的几十年前就已经下降。我们之前在尸检研究中表明,AD 中的这种代谢下降与大脑区域的线粒体功能障碍有关。为了确定年轻的高危个体是否表现出类似的线粒体功能下降,我们对年轻成年 APOEε4 携带者和非携带者的后扣带皮层进行了组织化学评估。在高危 ε4 携带者的后扣带皮层中,与非携带者相比,线粒体细胞色素氧化酶活性较低,尤其是在浅层皮质层中,这种模式与 AD 患者相似。除了一名 34 岁的 ε4 纯合子外,在同一区域,ε4 携带者没有增加可溶性淀粉样蛋白-β、组织学淀粉样蛋白-β 或 tau 病理学。这种功能性生物标志物可能在 AD 的早期检测和跟踪中证明有用,并表明线粒体机制可能在出现淀粉样蛋白或 tau 病理学之前导致 AD 的易感性。

相似文献

引用本文的文献

1
Accelerated midlife endocrine and bioenergetic brain aging in APOE4 females.APOE4 女性中中年期内分泌和生物能量学脑衰老加速
Front Aging Neurosci. 2025 Aug 18;17:1632877. doi: 10.3389/fnagi.2025.1632877. eCollection 2025.
10
Advances in Alzheimer's disease's pharmacological treatment.阿尔茨海默病药物治疗的进展。
Front Pharmacol. 2023 Jan 26;14:1101452. doi: 10.3389/fphar.2023.1101452. eCollection 2023.

本文引用的文献

4
The Alzheimer's disease mitochondrial cascade hypothesis: an update.阿尔茨海默病线粒体级联假说:最新进展
Exp Neurol. 2009 Aug;218(2):308-15. doi: 10.1016/j.expneurol.2009.01.011. Epub 2009 Jan 29.
5
Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.携带APOE-ε4等位基因的年轻人大脑活动的不同模式。
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7209-14. doi: 10.1073/pnas.0811879106. Epub 2009 Apr 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验